Business News • PR NewsWire • Evaluation of a Single 1.000 mg Iron Dose as Ferric Carboxymaltose (FCM) for Fatigue Treatment in Iron Deficient Women - PREFER

Evaluation of a Single 1.000 mg Iron Dose as Ferric Carboxymaltose (FCM) for Fatigue Treatment in Iron Deficient Women - PREFER

Evaluation of a Single 1.000 mg Iron Dose as Ferric Carboxymaltose (FCM) for Fatigue Treatment in Iron Deficient Women - PREFER

AMSTERDAM, June 15, 2012 /PRNewswire/ -- Dr Micheal Hedenus of the Haematology Unit of the Sundsval Hospital in Sweden will present promising results on a study on a single iron dose for fatigue treatment in iron deficient women at the 17th Congress of the European Hematology...

View More : http://www.prnewswire.com/news-releases/evaluation-of-a-single-1000-mg-iron-dose-as-ferric-carboxymaltose-fcm-for-fatigu...

Releted News by prnewswire

How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack

EHA Honorary Awards at the 17th Congress of EHA in Amsterdam